Poly(ethylene glycol) dimethacrylate - average Mn 2000

CAS : 25852-47-5

Ref. 3D-FP177951

Informations sur le produit

• Nom: Poly(ethylene glycol) dimethacrylate - average Mn 2000
• Synonymes: A 4Eg, Bisomer P 10W, Bisomer PEM 200, Blemmer 100, Blemmer PDE 1000, Blemmer PDE 150, Blemmer PDE 200, Blemmer PDE 400, Blemmer PDE 50R, Blemmer PDE 600, Blemmer PDE 6000, Chemlink 600, Chemlink CL 600, Eg 2500, Em 327, Ent 110, Fa 2200M, Fa 220M, Fa 260M, Fa 280M, Fancryl FA 220M, Fimoweld, Glycols, polyethylene, dimethacrylate, Graset T 303, Graset T 30D, Heneicosaethylene glycol dimethacrylate, Hydrogel, Hydrogel II, Hydrogel IV, Hydrogel VI, Light Acrylate P 303, Light Ester 14EG, Light Ester 4EG, Light Ester 9EG, M 281, Methacrylic acid, diester with polyethylene glycol, Mhoromer D 1120, Mhoromer D 1133, Mhoromer MFM 409, Miramer M 281, Miramer M 281T, NK Ester 14G, NK Ester 14KG, NK Ester 23G, NK Ester 35E, NK Ester 9G, New Frontier NF Bisomer PEM 200, Newfrontier NF Bisomer PEM 200, Nk 14G, Nk 1G, Nk 23G, Nk 9G, Oligoethylene glycol dimethacrylate, Pde 1000, Pde 400, Pde 600, Pde 6000, Peg 4000Dma, Peg-Dma, Pegdma 575, Pegma 14G, Pegma 23G, Pegma 9G, Pem 1000, Photomer 2050, Poly (10-200) ethylene glycol dimethacrylate, Poly(ethylene oxide) dimethacrylate, Poly(oxy-1,2-ethanediyl), α-(2-methyl-1-oxo-2-propen-1-yl)-ω-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, Polyethylene Glycol 400-Dimethacrylate, Polyethylene Glycol 600 Dimethacrylate, Polyethylene glycol dimethacrylate, Polyethylene glycol methacrylate, Polyoxyethylene dimethacrylate, Pu 280, Sartomer 210, Sartomer 603, Sartomer SR 210, Sartomer SR 252, Sr 210, Sr 210A, Sr 252, Sr 603, Sr 6030, Sr 603Op, Sr 740, Sr 740A, Tgm 13, α-(2-Methyl-1-oxo-2-propenyl)-ω-[(2-methyl-1-oxo-2-propenyl)o xy]poly(oxy-1,2-ethanediyl), α-Methacryloyl-ω-(methacryloyloxy)poly(oxyethylene)
• CAS: 25852-47-5

Description

PEG-DMA is a polymer that is used in medicine as a drug delivery system. It has been shown to be effective in reducing the size of adipose cells and increasing the production of preadipocytes. PEG-DMA can be crosslinked through covalent bonds, which gives it the ability to form a hydrogel. The hydrogel can then be used as an implantable material for pharmaceuticals. PEG-DMA has been shown to have good biocompatibility with cell morphology and can also be used as a coating for medical implants. Mathematical modelling has shown that PEG-DMA could potentially be used in personalized medicine by customizing it for specific people's needs.

• Marque: Biosynth

Propriétés chimiques

• Formule: (C₂H₄O)n•C₈H₁₀O₃
• Degré de pureté: Min. 95%